Peter Salzmann M.D.

Peter Salzmann M.D.

Chief Executive Officer and Director at Immunovant, Inc.

Are you Peter Salzmann M.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Peter Salzmann M.D.'s network.
  • FOLLOW changes in Peter Salzmann M.D.'s employment.
  • CONNECT with Peter Salzmann M.D. through your network of contacts.

Peter Salzmann M.D.'s Executive Work History


Current
CEO, Immunovant,
CEO, Immunovant
Equilar on 07/13/2022
Roivant Sciences Ltd.
Board Member,
Board Member
Immunovant, Inc. DEF 14A on 06/30/2022
Immunovant, Inc.
Chief Executive Officer and Director,
Chief Executive Officer and Director
Immunovant, Inc. S-1 on 01/17/2020
Immunovant, Inc.
Board Member,
Board Member
Corbus Pharmaceuticals Holdings, Inc. DEF 14A on 04/01/2022
Corbus Pharmaceuticals Holdings, Inc.
Past
To view Peter Salzmann M.D.'s complete executive work history,
Age
54
 

Peter Salzmann M.D.'s Biography


Dr. Salzmann has served as the Chief Executive Officer of Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases, since June 2019, and as a member of its board of directors since October 2019. Previously, from November 2018 to June 2019, he served as Global Brand Development Leader in Immunology at Eli Lilly and Company (NYSE: LLY), where he designed and executed a comprehensive indication development strategy and oversaw Phase 2 and 3 clinical trial execution. From March 2013 to October 2018, Dr. Salzmann was Head of U.S. Immunology at Eli Lilly, and Managing Director of Lilly Alps from January 2011 to April 2013. From January 2008 to December 2010, Dr. Salzmann was the Head of Marketing for Eli Lilly China. Dr. Salzmann earned a B.A. in Chemistry from Northwestern University, an M.D. from University of Chicago’s Pritzker School of Medicine, and an M.B.A. from Stanford University’s Graduate School of Business.

Source: Corbus Pharmaceuticals Holdings, Inc. on 10/10/2022

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Peter Salzmann M.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Peter Salzmann M.D.'s network.
  • FOLLOW changes in Peter Salzmann M.D.'s employment.
  • CONNECT with Peter Salzmann M.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Peter Salzmann M.D.

Peter Salzmann M.D.'s Connections (158)


Jim Haney
Former Vice President, Financial Planning and Analysis, Immunovant, Inc.
Beverly Paperiello
Former SVP, Program Strategy & CMO Chief of Staff, Immunovant, Inc.
Rod Saponjic PhD
Vice President, Clinical Operations, Immunovant, Inc.
Daniel Herz-Roiphe
Former Chief Operating Officer and General Counsel, Roivant Sciences Ltd.
Michael James Elliott Ph.D.
Physician-Scientist, Drug Developer, Early-Stage Life Science Investor, RI Bio
Eva Renee Barnett
Chief Financial Officer, Immunovant, Inc.
Parag V Meswani
Senior Vice President, Trofinetide – Rare Disease Franchise, ACADIA Pharmaceuticals Inc.
Eric Yuen M.D.
Board Member, Asceneuron
Keith S. Manchester M.D.
Board Member, Roivant Sciences Ltd.
Alan Kimura M.D., Ph.D.
Advisor, Rational Vaccines, Inc.